Group One Trading’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-67,922
| Closed | -$70.5K | – | 5952 |
|
|
2018
Q3 | $88K | Buy |
67,922
+7,500
| +12% | +$11.6K | ﹤0.01% | 3615 |
|
|
2018
Q2 | $82K | Buy |
60,422
+13,638
| +29% | +$20.9K | ﹤0.01% | 3681 |
|
|
2018
Q1 | $68K | Buy |
46,784
+4,300
| +10% | +$8.98K | ﹤0.01% | 3498 |
|
|
2017
Q4 | $96K | Buy |
42,484
+9,000
| +27% | +$22.8K | ﹤0.01% | 3389 |
|
|
2017
Q3 | $114K | Buy |
33,484
+20,900
| +166% | +$70.3K | ﹤0.01% | 3156 |
|
|
2017
Q2 | $45K | Buy |
+12,584
| New | +$41.5K | ﹤0.01% | 3564 |
|
|
2016
Q4 | – | Sell |
-939
| Closed | -$4K | – | 5288 |
|
|
2016
Q3 | $4K | Hold |
939
| – | – | ﹤0.01% | 4282 |
|
|
2016
Q2 | $2K | Sell |
939
-1,341
| -59% | -$4.85K | ﹤0.01% | 4485 |
|
|
2016
Q1 | $11K | Sell |
2,280
-6,669
| -75% | -$25.8K | ﹤0.01% | 3995 |
|
|
2015
Q4 | $35K | Sell |
8,949
-500
| -5% | -$2.3K | ﹤0.01% | 3630 |
|
|
2015
Q3 | $37K | Buy |
9,449
+3,892
| +70% | +$17.9K | ﹤0.01% | 3725 |
|
|
2015
Q2 | $26K | Buy |
5,557
+1,000
| +22% | +$9.59K | ﹤0.01% | 3923 |
|
|
2015
Q1 | $31K | Sell |
4,557
-4,688
| -51% | -$23.2K | ﹤0.01% | 3674 |
|
|
2014
Q4 | $30K | Buy |
+9,245
| New | +$37.2K | ﹤0.01% | 3739 |
|
Group One Trading's AST Position: Q4 2018 in Review
Group One Trading sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2018, closing a stake of 67,922 shares — an estimated $70.5K sold.
Group One Trading first reported a position in AST in Q4 2014 and held it in 14 quarters. The position peaked at $114K in Q3 2017. 46 funds tracked by Wall St. Rank hold AST as of Q4 2018.
- Group One Trading reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2018 after selling out during the quarter.
- Group One Trading sold 67,922 Asterias Biotherapeutics Inc. Series A shares in Q4 2018, an estimated $70.5K.
- Group One Trading first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 14 quarters.
- Group One Trading's Asterias Biotherapeutics Inc. Series A position peaked at $114K in Q3 2017.
- 46 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2018.
Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.